Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be ...

Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in the U.S.

Scientists have a new clue in the mystery of why younger people are getting more colon cancer. It may have to do with a toxin ...

It's unclear why colon cancer cases have doubled in people under 55 over the past two decades, a staggering rise that has ...

Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and ...

Four specific genes serve as a telltale clue to how potentially deadly stomach cancers will develop and progress, a new study ...

Erasca continues developing novel RAS-pathway cancer drugs, backed by funding through 2027 and promising early results. Find ...

Researchers from University of California San Diego have linked a bacterial toxin called colibactin to the increase in early-onset cases of colorectal cancer.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

A recent study links childhood exposure to a bacterial toxin in the colon to rising cases of colorectal cancer in young ...

Four specific genes serve as a telltale clue to how potentially deadly stomach cancers will develop and progress, a new study ...

Jim Higgins has an inherited cancer syndrome that has killed his father, sister, and two daughters. He fears NIH cuts will ...